Table 4 Univariate and multivariate logistic regression analysis for development of outcome
From: Long-term prognosis of clinically early IgA nephropathy is not always favorable
Variables | Wald | OR (95% CI) | P–value |
|---|---|---|---|
Secondary outcome | |||
Univariate | |||
Hypoalbuminemia | 9.68 | 13.33 (2.61–68.19) | 0.002 |
Global sclerosis | 3.58 | 3.00 (0.96–9.36) | 0.058 |
Segmental sclerosis | 7.23 | 5.86 (1.62–21.29) | 0.007 |
Interstitial fibrosis | 7.97 | 6.60 (1.78–24.45) | 0.005 |
Tubular atrophy | 5.72 | 4.65 (1.32–16.37) | 0.017 |
Use of RAS blockade | 5.97 | 6.88 (1.47–32.27) | 0.015 |
Multivariate analysis | |||
Hypoalbuminemia | 7.85 | 11.89 (2.10–67.23) | 0.005 |
Interstitial fibrosis | 6.06 | 5.93 (1.44–24.45) | 0.014 |
Composite outcome | |||
Univariate | |||
Hypoalbuminemia | 5.99 | 7.19 (1.48–34.86) | 0.014 |
Segmental sclerosis | 2.89 | 2.84 (0.85–9.47) | 0.089 |
Interstitial fibrosis | 5.85 | 4.31 (1.32–14.09) | 0.016 |
Tubular atrophy | 3.72 | 3.03 (0.98–9.47) | 0.054 |
Multivariate analysis | |||
Hypoalbuminemia | 4.75 | 6.18 (1.20–31.79) | 0.029 |
Interstitial fibrosis | 4.53 | 3.82 (1.11–13.11) | 0.033 |